Profil
Motasim Sirhan currently works at Elixir Medical Corp., as Chief Executive Officer & Director and Apama Medical, Inc., as Director.
Aktive Positionen von Motasim Sirhan
| Unternehmen | Position | Beginn |
|---|---|---|
Apama Medical, Inc.
 Apama Medical, Inc. Medical SpecialtiesHealth Technology Apama Medical, Inc. operates as a medical device company which focuses on the treatment of atrial fibrillation. The firm focuses on the electrophysiology market and offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation ablation. The company was founded by Amr Salahieh in 2009 and is headquartered in Campbell, CA. | Direktor/Vorstandsmitglied | - |
Elixir Medical Corp.
 Elixir Medical Corp. BiotechnologyHealth Technology Elixir Medical Corp. develops innovative products that combine state of the art medical devices with advanced pharmaceuticals. Its next-generation drug-eluting stent systems and bioresorbable coronary scaffold are designed to optimize localized drug delivery to provide safe and effective treatments for cardiovascular patients. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Apama Medical, Inc.
Apama Medical, Inc. Medical SpecialtiesHealth Technology Apama Medical, Inc. operates as a medical device company which focuses on the treatment of atrial fibrillation. The firm focuses on the electrophysiology market and offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation ablation. The company was founded by Amr Salahieh in 2009 and is headquartered in Campbell, CA. | Health Technology |
Elixir Medical Corp.
Elixir Medical Corp. BiotechnologyHealth Technology Elixir Medical Corp. develops innovative products that combine state of the art medical devices with advanced pharmaceuticals. Its next-generation drug-eluting stent systems and bioresorbable coronary scaffold are designed to optimize localized drug delivery to provide safe and effective treatments for cardiovascular patients. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Health Technology |
